Related Experiment Videos
1,2-Dibromoethane as an initiating agent for cell transformation
A Colacci1, P Perocco, M Vaccari
1Istituyo Nazionale per la Ricerca sul Cancro-Genova, Biotechnology Satellite Unit-Bologna, Italy.
Japanese Journal of Cancer Research : Gann
|February 1, 1995
Summary
1,2-Dibromoethane effectively initiates cell transformation at low doses, as shown by a sensitive two-stage assay. This study demonstrates its potential as a carcinogen, even at concentrations below previously established thresholds.
Area of Science:
- Chemical carcinogenesis
- Cellular transformation assays
Background:
- The two-stage transformation assay enhances cellular sensitivity to chemical agents, enabling the detection of carcinogens acting as initiating agents.
- 1,2-Dibromoethane (EDB) is a halogenated aliphatic compound representative of chemicals requiring sensitive detection methods for carcinogenic potential.
Purpose of the Study:
- To evaluate the initiating potential of 1,2-dibromoethane in a two-stage cell transformation assay using BALB/c 3T3 cells.
- To determine the effective dosage range of 1,2-dibromoethane for inducing heritable changes indicative of cellular transformation.
Main Methods:
- Utilizing a two-stage transformation assay with BALB/c 3T3 cells.
- Administering 1,2-dibromoethane at dosages ranging from 16 microM to 128 microM.
- Assessing the induction of heritable changes and transformed foci under conditions of chronic promotion or extended cell replication.
Main Results:
- 1,2-Dibromoethane induced heritable changes in BALB/c 3T3 cells across a dose range of 16 microM to 128 microM, with effects observed even at lower concentrations than previously reported.
- All tested dosages, except the lowest which showed borderline effects, resulted in the formation of fully transformed foci.
- The initiated cells were identifiable through both chronic promoting treatment and additional rounds of cell replication.
Conclusions:
- 1,2-Dibromoethane demonstrates significant initiating activity in the two-stage cell transformation assay.
- The compound can act as a carcinogen by initiating cellular transformation at low, previously inefficient doses.
- The findings underscore the utility of the two-stage assay for identifying initiating carcinogens.